Vincent Valentine, MD
Professor, Division of Pulmonary and Critical Care Medicine
Vincent Valentine, MD
Professor of Medicine
Pulmonary and Critical Care Medicine
Medical Director, UTMB Texas Transplant Center
Director, Lung Transplantation
Department of Internal Medicine
University of Texas Medical Branch
301 University Blvd.
Galveston, TX 77555-0772
Phone: 409.772.9838
Fax: 409.747.1901
vgvalent@utmb.edu
Education
| Degree/Training Completed | Year | Name & Location |
| M.D. | 1987 | Louisiana State University, New Orleans, LA |
| Residency | 1990 | Charity Hospital, LSU Affiliated Hospitals New Orleans, LA |
| Fellow | 1993 | Stanford University Hospital, Stanford, CA |
| Advanced Fellow | 1994 | Stanford University Hospital, Stanford, CA |
Research Interests:
- Role of neutrophils in the pathogenesis of cystic fibrosis
- Managing patients with cystic fibrosis
- Improving outcomes for heart-lung and lung transplant recipients
- Genetic influences on the immunopathogenesis of idiopathic pulmonary fibrosis
- Managing CMV Disease in transplantation
- Defining and managing obliterative bronchiolitis/bronchiolitis obliterans syndrome in the lung allograft
- Pulmonary complications in the immunocompromised host
- Managing septic shock
Selected Publications
- Valentine VG, Gupta MR, Walker JE, Seoane L, Bonvillain RW, Lombard GA, Weill D, Dhillon GS: Effect of etiology and timing of respiratory tract infections on the development of bronchiolitis obliterans syndrome. J Heart Lung Transplant 28(2):163-169, 2009
- Painter RG, Marrero L, Lombard GA, Valentine VG, Nauseef WM, Wang G. CFTR-mediated halide transport in phagosomes of human neutrophils. J Leukoc Biol 87(5):933-942, 2010 PMID 20089668; PMCID2858676
- Gilani SR, Vuga LJ, Lindell KO, Gibson KF, Xue J, Kaminski N, Valentine VG, Lindsay EK, George MP, Steele C, Duncan SR. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010 Jan;5:e8959 PMID20126467; PMCID2813297
- Palmer SM, Limaye AP, Banks M, Gallup D, Chapman J, Lawrence EC, Dunitz J, Milstone A, Reynolds J, Yung GL, Chan KM, Aris R, Garrity E, Valentine V, McCall J, Chow SC, Davis RD, Avery R. Extended valganciclovir prophylaxis to prevent cytomegalovirus (CMV) after lung transplantation: a randomized, controlled trial. Ann Intern Med 2010 Jun 15;152(12):761-769; PMID 20547904
- Bhorade S, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Alex CG, Bag R, Deoliveira NC, Husain A, Vigneswaran WT, Charbeneau J, Krishnan JA, Durazo-Arvizu R, Norwick L, Garrity E. Comparison of Sirolimus to Azathioprine in a Tacrolimus Based Immunosuppressive Regimen in Lung Transplantation. Am J Respir Crit Care Med. 2010 Sep 10. PMID20833822
Clinical Interests:
- Lung Transplantation
- Advanced Pulmonary Diseases
- Cystic Fibrosis
- Diffuse Parenchymal Lung Disease
- Lymphangioleiomyomatosis (LAM)
Patient Care:
Victory Lakes Town Center
2660 Gulf Freeway South
League City, Texas 77573
832.505.2000
Transplant Clinic: 832.505.2350
Fax: 832.337.0719
The UTMB Center for Global Health Education (CGHE) is dedicated to the training of tomorrow's global health work force to improve health for the people of Texas and around the world. Check out their website for more information on the global health programs and education going on in our department.
Featured Videos
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.
Currently available protocols are:- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.
